SlideShare a Scribd company logo
1 of 17
Download to read offline
1
Sponsor and Investigator Responsibilities for
Management of The Investigational Product
Good Clinical People
ICH-GCP Foundation Course
2
A pharmaceutical form of an active ingredient or
placebo being tested or used as a reference in a clinical
trial, including a product with a marketing authorisation
when:
• Used or assembled in a way different from the
approved form,
• Used for an unapproved indication, or
• Used to gain further information about an approved
use.
Investigational Product (IP)
©2019 Good Clinical People Ltd.
3
“The available nonclinical and clinical information
on an investigational product should be adequate
to support the proposed clinical trial.”
ICH-GCP Principle 4
4
When planning trials, the sponsor ensures
that sufficient safety and efficacy data from
nonclinical studies and/or clinical trials are
available to support human exposure by the
route, at the dosages, for the duration, and
in the trial population to be studied
Information on Investigational Product
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
5
The Investigator’s Brochure (IB) is a
compilation of the clinical and non clinical
data on the investigational product that are
relevant to the study of the product in human
subjects.
The sponsor updates the Investigator's
Brochure as significant new information
becomes available.
Information on Investigational
Product(s)
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
6
What is a
nonclinical study?
It is a biomedical study which is not
performed on human subjects. It can
be a study conducted on animals (in
vivo) or in a lab (in vitro).
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
7
“Investigational products should be manufactured,
handled, and stored in accordance with applicable
good manufacturing practice (GMP). They should
be used in accordance with the approved protocol.”
ICH-GCP Principle 12
8
The sponsor:
(a) Takes steps to ensure that the investigational
product is stable over the period of use.
(b) Maintains sufficient quantities of the
investigational product used in the trials to
reconfirm specifications, should this become
necessary, and maintain records of batch
sample analyses and characteristics. To the
extent stability permits, samples should be
retained either until the analyses of the trial
data are complete or as required by the
applicable regulatory requirements,
whichever represents the longer retention
period.
Investigational Product Management:
Sponsor’s Responsibilities
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
9
The sponsor ensures that written procedures include
instructions that the investigator/institution should follow
for the handling and storage of investigational product for
the trial and documentation thereof.
The procedures address adequate and safe receipt,
handling, storage, dispensing, retrieval of unused product
from subjects, and return of unused investigational product
to the sponsor (or alternative disposition if authorized by
the sponsor and in compliance with the applicable
regulatory requirements).
Supplying and Handling
Investigational Product(s)
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
10
Storage Conditions Packaging Labelling Unblinding
Storage, Packaging and Labelling
The sponsor
determines, for the
investigational
product, acceptable
storage temperatures,
conditions, times,
reconstitution fluids
and procedures, and
devices for product
infusion, if any.
The sponsor packages
the investigational
product to prevent
contamination and
unacceptable
deterioration during
transport and storage.
The sponsor ensures
that the investigational
product is labelled in a
manner that protects
the blinding and
complies with applicable
regulatory requirements.
In blinded trials, the
coding system for the
investigational product
includes a mechanism
that permits rapid
identification of the
product in case of a
medical emergency but
does not permit
undetectable breaks of
the blinding.
©2019 Good Clinical People Ltd.
11
The sponsor supplies the investigators with the investigational
product only after all required documentation has been obtained.
The sponsor ensures timely delivery of investigational product to
the investigators.
The sponsor maintains records that document shipment, receipt,
disposition, return, and destruction of the investigational product.
Maintains a system for retrieving investigational products and
documenting this retrieval.
Maintains a system for the disposition of unused investigational
product and for the documentation of this disposition.
Sponsor’s Responsibilities: Supplying
and Handling the Investigational
Product(s)
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
12
Do these requirements apply
to the comparator? A
placebo?
Yes, they do, as the comparator,
including placebo, is included in
ICH-GCP’s definition of an IP.
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
13
Can you explain what
randomization is?
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
Randomization is the process whereby a subject is assigned to a
treatment arm (either an actual dose of the investigational product under
study or to a comparator) automatically to ensure that the trial is
balanced across different stratified groups.
Randomization is often done using Interactive Response Technologies
(IRT). These come in the form of an internet-based Interactive Web
Response System (IWRS) or a telephone-based Interactive Voice
Response System (IVRS).
14
The investigator follows the trial's randomization
procedures, if any, and ensures that the code is broken
only in accordance with the protocol.
If the trial is blinded, the investigator promptly
documents and explains to the sponsor any premature
unblinding (e.g. accidental unblinding, unblinding due to
a serious adverse event) of the investigational product.
Randomization Procedures
and Unblinding
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
15
Investigator’s Responsibilities:
Investigational Product
Responsibility for investigational product accountability at the trial site
rests with the investigator/institution.
The investigator:
• Maintains records of the product's delivery to the trial site, the
inventory at the site, the use by each subject, and the return to the
sponsor or alternative disposition of unused product.
• Stores the investigational product as specified by the sponsor and in
accordance with applicable regulatory requirements.
• Ensures that the investigational product is used only in accordance with
the approved protocol.
The investigator, or a person designated by the investigator/institution,
explains the correct use of the investigational product to each subject and
check, at intervals appropriate for the trial, that each subject is following
the instructions properly.
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
16
Can the Investigator
delegate IP management
responsibilities to a member
of his/her team?
Yes. Where allowed/required, the investigator/institution
may assign some or all of the investigator's duties for
investigational product accountability at the trial site to an
appropriate pharmacist or another appropriate individual
who is under the supervision of the investigator/institution.
©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
17
Want to learn more? Complete our ICH GCP Foundation
Course. Enrolll using either the QR code below or this link
https://goodclinicalpeople.thinkific.com/courses/GCPfound
ationcourse
Mallorie Mitchell-Dellac
goodclinicalpeople.com
+44(0)7539 505 344
ICHGCP20 (20% off the course)
Good Clinical People
ICH-GCP Foundation Course

More Related Content

What's hot

Imp management at site (UA)
Imp management at site (UA)Imp management at site (UA)
Imp management at site (UA)Pshot
 
Investigator's brochure
Investigator's brochureInvestigator's brochure
Investigator's brochureAtul Adhikari
 
Good Clinical Practice (GCP)
Good Clinical Practice (GCP)Good Clinical Practice (GCP)
Good Clinical Practice (GCP)Devyani Joshi
 
Good Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilGood Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilSwapnil Patil
 
STUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICS
STUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICSSTUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICS
STUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICSMegha bhise
 
Roles And Responsibilities Of Monitor
Roles And Responsibilities Of MonitorRoles And Responsibilities Of Monitor
Roles And Responsibilities Of Monitorlekshmilnair
 
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines VanshikaGupta948537
 
Basics of ich gcp campus kortrijk 2012 yge
Basics of ich gcp campus kortrijk 2012 ygeBasics of ich gcp campus kortrijk 2012 yge
Basics of ich gcp campus kortrijk 2012 ygeYves Geysels
 
MONITORING VISIT - INVESTIGATIONAL PRODUCT
MONITORING VISIT - INVESTIGATIONAL PRODUCTMONITORING VISIT - INVESTIGATIONAL PRODUCT
MONITORING VISIT - INVESTIGATIONAL PRODUCTLincyAsha
 
Overview of Audits and Inspections in Clinical Research
Overview of Audits and Inspections in Clinical ResearchOverview of Audits and Inspections in Clinical Research
Overview of Audits and Inspections in Clinical ResearchAshish K Awadhiya
 
Indian gcp guidelines[647]
Indian gcp guidelines[647]Indian gcp guidelines[647]
Indian gcp guidelines[647]AkhileshAkki6
 
Monitoring and auditing in clinical trials
Monitoring and auditing in clinical trialsMonitoring and auditing in clinical trials
Monitoring and auditing in clinical trialsJyotsna Kapoor
 
FDA Warning letter
FDA Warning letterFDA Warning letter
FDA Warning letterSridhar S
 

What's hot (20)

Imp management at site (UA)
Imp management at site (UA)Imp management at site (UA)
Imp management at site (UA)
 
Ich e6(r1)
Ich e6(r1)Ich e6(r1)
Ich e6(r1)
 
Investigator's brochure
Investigator's brochureInvestigator's brochure
Investigator's brochure
 
Good Clinical Practice (GCP)
Good Clinical Practice (GCP)Good Clinical Practice (GCP)
Good Clinical Practice (GCP)
 
Good Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilGood Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patil
 
Ich gcp
Ich gcpIch gcp
Ich gcp
 
Indian gcp vs ich gcp
Indian gcp vs ich gcpIndian gcp vs ich gcp
Indian gcp vs ich gcp
 
STUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICS
STUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICSSTUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICS
STUDIES IN SUPPORT OF SPECIAL POPULATIONS : GERIATRICS
 
Monitoring Visits
Monitoring VisitsMonitoring Visits
Monitoring Visits
 
Roles And Responsibilities Of Monitor
Roles And Responsibilities Of MonitorRoles And Responsibilities Of Monitor
Roles And Responsibilities Of Monitor
 
505 (b) (2)
505 (b) (2)505 (b) (2)
505 (b) (2)
 
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
 
Basics of ich gcp campus kortrijk 2012 yge
Basics of ich gcp campus kortrijk 2012 ygeBasics of ich gcp campus kortrijk 2012 yge
Basics of ich gcp campus kortrijk 2012 yge
 
MONITORING VISIT - INVESTIGATIONAL PRODUCT
MONITORING VISIT - INVESTIGATIONAL PRODUCTMONITORING VISIT - INVESTIGATIONAL PRODUCT
MONITORING VISIT - INVESTIGATIONAL PRODUCT
 
Overview of Audits and Inspections in Clinical Research
Overview of Audits and Inspections in Clinical ResearchOverview of Audits and Inspections in Clinical Research
Overview of Audits and Inspections in Clinical Research
 
Indian gcp guidelines[647]
Indian gcp guidelines[647]Indian gcp guidelines[647]
Indian gcp guidelines[647]
 
Site qualification visit
Site qualification visitSite qualification visit
Site qualification visit
 
Clinical trial monitoring
Clinical trial monitoringClinical trial monitoring
Clinical trial monitoring
 
Monitoring and auditing in clinical trials
Monitoring and auditing in clinical trialsMonitoring and auditing in clinical trials
Monitoring and auditing in clinical trials
 
FDA Warning letter
FDA Warning letterFDA Warning letter
FDA Warning letter
 

Similar to ICH GCP - Sponsor and Investigator's Responsibilities for Management of the Investigational Product

Sponsor responsibilities
Sponsor responsibilitiesSponsor responsibilities
Sponsor responsibilitiesRiyadh Rehani
 
Role and Responsiblities of Sponsor as per ICH GCP.pptx
Role and Responsiblities of Sponsor as per ICH GCP.pptxRole and Responsiblities of Sponsor as per ICH GCP.pptx
Role and Responsiblities of Sponsor as per ICH GCP.pptxsreesujithra
 
Presentation on Clinical Trial
Presentation on Clinical TrialPresentation on Clinical Trial
Presentation on Clinical TrialSandeepkarki13
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsDeepak Kumar
 
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Dr B Naga Raju
 
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Dr B Naga Raju
 
GCP for Investigators by Valentyna
GCP for Investigators by ValentynaGCP for Investigators by Valentyna
GCP for Investigators by ValentynaValentyna Korniyenko
 
ROLES AND RESPONSIBILITIES OF sponsor and CRO.pptx
ROLES AND RESPONSIBILITIES OF sponsor and CRO.pptxROLES AND RESPONSIBILITIES OF sponsor and CRO.pptx
ROLES AND RESPONSIBILITIES OF sponsor and CRO.pptxPraveen kumar S
 
Sponsor Responsibilities ppt
Sponsor  Responsibilities pptSponsor  Responsibilities ppt
Sponsor Responsibilities pptSantosh Zarkariya
 
Good Clinical Practice and Pharmacovigilance
Good Clinical Practice and PharmacovigilanceGood Clinical Practice and Pharmacovigilance
Good Clinical Practice and PharmacovigilanceMd. Zakaria Faruki
 
Clinical trials: Terminology
Clinical trials: TerminologyClinical trials: Terminology
Clinical trials: TerminologyPradeep H
 
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator MOHAMMEDSALEEMJM
 
Clinical trail team ( stake holders )
Clinical trail team ( stake holders )Clinical trail team ( stake holders )
Clinical trail team ( stake holders )Irene Vadakkan
 
4.1.2 investigator.pptx
4.1.2 investigator.pptx4.1.2 investigator.pptx
4.1.2 investigator.pptxSyedaErum5
 
Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxRoshan Yadav
 
Guidelines for principles and rules for good clinical practices of advanced t...
Guidelines for principles and rules for good clinical practices of advanced t...Guidelines for principles and rules for good clinical practices of advanced t...
Guidelines for principles and rules for good clinical practices of advanced t...Serkan Kaçar
 

Similar to ICH GCP - Sponsor and Investigator's Responsibilities for Management of the Investigational Product (20)

Sponsor responsibilities
Sponsor responsibilitiesSponsor responsibilities
Sponsor responsibilities
 
Role and Responsiblities of Sponsor as per ICH GCP.pptx
Role and Responsiblities of Sponsor as per ICH GCP.pptxRole and Responsiblities of Sponsor as per ICH GCP.pptx
Role and Responsiblities of Sponsor as per ICH GCP.pptx
 
Presentation on Clinical Trial
Presentation on Clinical TrialPresentation on Clinical Trial
Presentation on Clinical Trial
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical Trials
 
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
 
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
 
Sponsor
SponsorSponsor
Sponsor
 
GCP for Investigators by Valentyna
GCP for Investigators by ValentynaGCP for Investigators by Valentyna
GCP for Investigators by Valentyna
 
ROLES AND RESPONSIBILITIES OF sponsor and CRO.pptx
ROLES AND RESPONSIBILITIES OF sponsor and CRO.pptxROLES AND RESPONSIBILITIES OF sponsor and CRO.pptx
ROLES AND RESPONSIBILITIES OF sponsor and CRO.pptx
 
Sponsor Responsibilities ppt
Sponsor  Responsibilities pptSponsor  Responsibilities ppt
Sponsor Responsibilities ppt
 
Good Clinical Practice and Pharmacovigilance
Good Clinical Practice and PharmacovigilanceGood Clinical Practice and Pharmacovigilance
Good Clinical Practice and Pharmacovigilance
 
ICH GCP.ppt
ICH GCP.pptICH GCP.ppt
ICH GCP.ppt
 
Clinical trials: Terminology
Clinical trials: TerminologyClinical trials: Terminology
Clinical trials: Terminology
 
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
 
GCP guidelines
GCP guidelines GCP guidelines
GCP guidelines
 
Clinical trail team ( stake holders )
Clinical trail team ( stake holders )Clinical trail team ( stake holders )
Clinical trail team ( stake holders )
 
4.1.2 investigator.pptx
4.1.2 investigator.pptx4.1.2 investigator.pptx
4.1.2 investigator.pptx
 
GCP ppdf
GCP ppdfGCP ppdf
GCP ppdf
 
Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptx
 
Guidelines for principles and rules for good clinical practices of advanced t...
Guidelines for principles and rules for good clinical practices of advanced t...Guidelines for principles and rules for good clinical practices of advanced t...
Guidelines for principles and rules for good clinical practices of advanced t...
 

Recently uploaded

Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
Physiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisPhysiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisNilofarRasheed1
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...bkling
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Microbiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxMicrobiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxkitati1
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?Ryan Addison
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 

Recently uploaded (20)

Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
Physiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisPhysiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid Arthritis
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Microbiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxMicrobiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptx
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 

ICH GCP - Sponsor and Investigator's Responsibilities for Management of the Investigational Product

  • 1. 1 Sponsor and Investigator Responsibilities for Management of The Investigational Product Good Clinical People ICH-GCP Foundation Course
  • 2. 2 A pharmaceutical form of an active ingredient or placebo being tested or used as a reference in a clinical trial, including a product with a marketing authorisation when: • Used or assembled in a way different from the approved form, • Used for an unapproved indication, or • Used to gain further information about an approved use. Investigational Product (IP) ©2019 Good Clinical People Ltd.
  • 3. 3 “The available nonclinical and clinical information on an investigational product should be adequate to support the proposed clinical trial.” ICH-GCP Principle 4
  • 4. 4 When planning trials, the sponsor ensures that sufficient safety and efficacy data from nonclinical studies and/or clinical trials are available to support human exposure by the route, at the dosages, for the duration, and in the trial population to be studied Information on Investigational Product ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 5. 5 The Investigator’s Brochure (IB) is a compilation of the clinical and non clinical data on the investigational product that are relevant to the study of the product in human subjects. The sponsor updates the Investigator's Brochure as significant new information becomes available. Information on Investigational Product(s) ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 6. 6 What is a nonclinical study? It is a biomedical study which is not performed on human subjects. It can be a study conducted on animals (in vivo) or in a lab (in vitro). ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 7. 7 “Investigational products should be manufactured, handled, and stored in accordance with applicable good manufacturing practice (GMP). They should be used in accordance with the approved protocol.” ICH-GCP Principle 12
  • 8. 8 The sponsor: (a) Takes steps to ensure that the investigational product is stable over the period of use. (b) Maintains sufficient quantities of the investigational product used in the trials to reconfirm specifications, should this become necessary, and maintain records of batch sample analyses and characteristics. To the extent stability permits, samples should be retained either until the analyses of the trial data are complete or as required by the applicable regulatory requirements, whichever represents the longer retention period. Investigational Product Management: Sponsor’s Responsibilities ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 9. 9 The sponsor ensures that written procedures include instructions that the investigator/institution should follow for the handling and storage of investigational product for the trial and documentation thereof. The procedures address adequate and safe receipt, handling, storage, dispensing, retrieval of unused product from subjects, and return of unused investigational product to the sponsor (or alternative disposition if authorized by the sponsor and in compliance with the applicable regulatory requirements). Supplying and Handling Investigational Product(s) ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 10. 10 Storage Conditions Packaging Labelling Unblinding Storage, Packaging and Labelling The sponsor determines, for the investigational product, acceptable storage temperatures, conditions, times, reconstitution fluids and procedures, and devices for product infusion, if any. The sponsor packages the investigational product to prevent contamination and unacceptable deterioration during transport and storage. The sponsor ensures that the investigational product is labelled in a manner that protects the blinding and complies with applicable regulatory requirements. In blinded trials, the coding system for the investigational product includes a mechanism that permits rapid identification of the product in case of a medical emergency but does not permit undetectable breaks of the blinding. ©2019 Good Clinical People Ltd.
  • 11. 11 The sponsor supplies the investigators with the investigational product only after all required documentation has been obtained. The sponsor ensures timely delivery of investigational product to the investigators. The sponsor maintains records that document shipment, receipt, disposition, return, and destruction of the investigational product. Maintains a system for retrieving investigational products and documenting this retrieval. Maintains a system for the disposition of unused investigational product and for the documentation of this disposition. Sponsor’s Responsibilities: Supplying and Handling the Investigational Product(s) ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 12. 12 Do these requirements apply to the comparator? A placebo? Yes, they do, as the comparator, including placebo, is included in ICH-GCP’s definition of an IP. ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 13. 13 Can you explain what randomization is? ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com Randomization is the process whereby a subject is assigned to a treatment arm (either an actual dose of the investigational product under study or to a comparator) automatically to ensure that the trial is balanced across different stratified groups. Randomization is often done using Interactive Response Technologies (IRT). These come in the form of an internet-based Interactive Web Response System (IWRS) or a telephone-based Interactive Voice Response System (IVRS).
  • 14. 14 The investigator follows the trial's randomization procedures, if any, and ensures that the code is broken only in accordance with the protocol. If the trial is blinded, the investigator promptly documents and explains to the sponsor any premature unblinding (e.g. accidental unblinding, unblinding due to a serious adverse event) of the investigational product. Randomization Procedures and Unblinding ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 15. 15 Investigator’s Responsibilities: Investigational Product Responsibility for investigational product accountability at the trial site rests with the investigator/institution. The investigator: • Maintains records of the product's delivery to the trial site, the inventory at the site, the use by each subject, and the return to the sponsor or alternative disposition of unused product. • Stores the investigational product as specified by the sponsor and in accordance with applicable regulatory requirements. • Ensures that the investigational product is used only in accordance with the approved protocol. The investigator, or a person designated by the investigator/institution, explains the correct use of the investigational product to each subject and check, at intervals appropriate for the trial, that each subject is following the instructions properly. ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 16. 16 Can the Investigator delegate IP management responsibilities to a member of his/her team? Yes. Where allowed/required, the investigator/institution may assign some or all of the investigator's duties for investigational product accountability at the trial site to an appropriate pharmacist or another appropriate individual who is under the supervision of the investigator/institution. ©2019 Good Clinical People Ltd. – Images from Volhah, used under license from Shutterstock.com
  • 17. 17 Want to learn more? Complete our ICH GCP Foundation Course. Enrolll using either the QR code below or this link https://goodclinicalpeople.thinkific.com/courses/GCPfound ationcourse Mallorie Mitchell-Dellac goodclinicalpeople.com +44(0)7539 505 344 ICHGCP20 (20% off the course) Good Clinical People ICH-GCP Foundation Course